Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Valagussa

Showing results (171-180 of 196) with videos related to

Pageof 20
Sort By:
Leukemia|July 28, 2006
Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantationP Corradini, C Tarella, F Zallio, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Primary chemotherapy for resectable breast cancerG Bonadonna, U Veronesi, C Brambilla, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPPV Bonfante, A Santoro, S Viviani, et al.
British Journal of Haematology|November 25, 1998
Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's diseaseV Bonfante, S Viviani, A Santoro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1993
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year updateA M Gianni, S Siena, M Bregni, et al.
Cancer Treatment Reports|January 1, 1981
Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of MilanG Bonadonna, A Rossi, G Tancini, et al.
The New England Journal of Medicine|February 19, 1976
Combination chemotherapy as an adjuvant treatment in operable breast cancerG Bonadonna, E Brusamolino, P Valagussa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative GroupG Bonadonna, M Zambetti, C Bumma, et al.
The Cancer Journal From Scientific American|October 20, 1999
Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's diseaseS Viviani, V Bonfante, A Santoro, et al.
European Journal of Haematology. Supplementum|August 7, 2001
High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's diseaseV Bonfante, S Viviani, L Devizzi, et al.
Pageof 20

Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
Leukemia|July 28, 2006
Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantationP Corradini, C Tarella, F Zallio, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Primary chemotherapy for resectable breast cancerG Bonadonna, U Veronesi, C Brambilla, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPPV Bonfante, A Santoro, S Viviani, et al.
British Journal of Haematology|November 25, 1998
Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's diseaseV Bonfante, S Viviani, A Santoro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1993
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year updateA M Gianni, S Siena, M Bregni, et al.
Cancer Treatment Reports|January 1, 1981
Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of MilanG Bonadonna, A Rossi, G Tancini, et al.
The New England Journal of Medicine|February 19, 1976
Combination chemotherapy as an adjuvant treatment in operable breast cancerG Bonadonna, E Brusamolino, P Valagussa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative GroupG Bonadonna, M Zambetti, C Bumma, et al.
The Cancer Journal From Scientific American|October 20, 1999
Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's diseaseS Viviani, V Bonfante, A Santoro, et al.
European Journal of Haematology. Supplementum|August 7, 2001
High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's diseaseV Bonfante, S Viviani, L Devizzi, et al.
Pageof 20